Cited by 604Barrier Structure and Function StudiesNanoparticle-Based Drug DeliveryDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Open access

Xie, Jinbing, Shen, Zheyu, Anraku, Yasutaka, Kataoka, Kazunori, Chen, Xiaoyuan·2019·Biomaterials

DOI 10.1016/j.biomaterials.2019.119491PMC PMC6915305

Open this paper in CoChat — free account

Abstract

Increasing attention has been paid to the diseases of central nervous system (CNS). The penetration efficiency of most CNS drugs into the brain parenchyma is rather limited due to the existence of blood-brain barrier (BBB). Thus, BBB crossing for drug delivery to CNS remains a significant challenge in the development of neurological therapeutics. Because of the advantageous properties (e.g., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseases. This review summarizes the current understanding of the physiological structure of BBB, and provides various nanomaterial-based BBB-crossing strategies for brain delivery of theranostic agents, including intranasal delivery, temporary disruption of BBB, local delivery, cell penetrating peptide (CPP) mediated BBB-crossing, receptor mediated BBB-crossing, shuttle peptide mediated BBB-crossing, and cells mediated BBB-crossing. Clinicians, biologists, material scientists and chemists are expected to be interested in this review.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2019.119491

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Retracted
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,625
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbaşak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,442
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 1,040
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,038
Cloning by functional expression of a member of the glutamate receptor family
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W., & Heinemann, S. F. (1989) · Nature · doi:10.1038/342643a0 · Cited by 1,016

Show all 236 references

Research works printed but not linked: 1

Feng, 2017, Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting, Theranostics, 7, 1875, 10.7150/thno.18985 · DOI

Sorted by citations

Items 301–400 of 604

Emerging Nano‐Immunotherapeutic Approaches to Glioma
Jin, N., Yang, W., Xie, Y., Yu, M., Chen, Y., & Zhang, J. (2023) · Small Structures · doi:10.1002/sstr.202300016 · Cited by 15
Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review
Won, S., An, J., Song, H., Im, S., You, G., Lee, S., Koo, K.-I., & Hwang, C. H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1137096 · Cited by 15
Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: a systematic review and meta-analysis
Li, M.-T., Wu, Q.-Q., Li, J.-B., & Chen, J. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.107033 · Cited by 16
The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review
Kapoor, D. U., Chilkapalli, S. C., Prajapati, B. G., Rodriques, P., Patel, R. J., Singh, S. K., & Bhattacharya, S. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010268824231122041237 · Cited by 17
Small functionalized iron oxide nanoparticles for dual brain magnetic resonance imaging and fluorescence imaging
Wei, R., Liu, Y., Gao, J., Yong, V. W., & Xue, M. (2021) · RSC Advances · doi:10.1039/d0ra10392f · Cited by 15
Original boron cluster covalent with poly-zwitterionic BODIPYs for boron neutron capture therapy agent
Zhao, F., Hu, K., Shao, C., & Jin, G. (2021) · Polymer Testing · doi:10.1016/j.polymertesting.2021.107269 · Cited by 15
The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis
Kim, W., Kim, G., Cho, H., & Choi, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081134 · Cited by 15
Brain-targeted polymersome codelivery of siRNA and temozolomide for effective glioblastoma chemo-RNAi synergistic therapy
Zheng, M., Yan, C., Yang, Q., Zhu, F., Du, Q., Xia, X., Morsch, M., Lee, A., Yin, J., Zou, Y., et al. (2022) · ChemPhysMater · doi:10.1016/j.chphma.2022.01.001 · Cited by 15
Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties
Österlund, N., Wärmländer, S. K. T. S., & Gräslund, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040823 · Cited by 15
Novel Therapeutic Approaches of Ion Channels and Transporters in Cancer
Ramírez, A., García‐Quiroz, J., Aguilar-Eslava, L., Sánchez-Pérez, Y., & Camacho, J. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_28 · Cited by 15
Lactoferrin Nanoparticle-Vanadium Complex: A Promising High-Efficiency Agent against Glioblastoma by Triggering Autophagy and Ferroptosis
Gai, S., Yan, Q., Li, S., Zhong, X., Qin, Y., & Jiang, M. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02696 · Cited by 14
Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors
Chen, Z., Sang, L., Qixi, Z., Li, X., Liu, Y., & Bai, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101661 · Cited by 15
Targeted protein degradation technologies: Emerging mechanisms and nano-based innovations
Hou, M., Zhao, R., Wang, S., Jiang, B., & Yan, X. (2025) · Nano Research · doi:10.26599/nr.2025.94907983 · Cited by 14
Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application
Aili, Y., Maimaitiming, N., Hu, Q., Ji, W., Fan, G., Wang, Z., & Wang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.983878 · Cited by 14
The battle of lipid-based nanocarriers against blood-brain barrier: a critical review
Abla, K. K., & Mehanna, M. M. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2247583 · Cited by 15
Targeted strategies to deliver boron agents across the blood–brain barrier for neutron capture therapy of brain tumors
Lan, G., Song, Q., Luan, Y., & Cheng, Y. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123747 · Cited by 14
Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery
He, Y., Zhou, C., Jiang, S., Lan, W.-Q., Zhang, F., Tao, X., & Chen, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1292807 · Cited by 14
The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy
Wu, H., Wang, Y., Ren, Z., Cong, H., Shen, Y., & Yu, B. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109996 · Cited by 14
LncRNA regulation in ischemic stroke and their application prospects
Chen, Q., Xu, X., Li, S., & Xiong, T. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00924 · Cited by 15
Microvesicles carrying EV71 virions cross BBB through endocytic pathway to induce brain injury
Tian, X., Liu, B., Li, L., Yuan, M., You, Q., Zhang, R., Chen, D., Cheng, M., Zheng, N., He, M., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02195-y · Cited by 14
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges
Kaur, J., Thakran, A., & Naqvi, S. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101060 · Cited by 13
Microfluidic-based nanocarriers for overcoming biological barriers in therapeutic delivery systems
Gharatape, A., Niasari-Naslaji, Z., Chain, J. L., Tabatabaei, S. N., & Faridi-Majidi, R. (2025) · Nanoscale · doi:10.1039/d5nr02322j · Cited by 13
Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation
Huang, T., Wu, J., Mu, J., & Gao, J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00605 · Cited by 13
Hydroxysafflor yellow A-loaded biomimetic liposomes alleviate HHcy-induced atherosclerosis by regulating methylation related autophagy
Li, Y., Yang, A., Sun, Y., Liu, D., You, P., Zeng, Y., Quan, S., Zhang, H., Zhang, H., Ma, S., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.111807 · Cited by 15
The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases
Li, J., Zhang, H., Jiang, Y., Li, N., Zhu, A., Zhang, Y., Feng, K., Zeng, W., Di, L., & Wang, R. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102169 · Cited by 15
The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges
Zhang, R., Li, X., & Zhang, S. (2024) · Microorganisms · doi:10.3390/microorganisms12061053 · Cited by 13
Cyclic Peptides KS-133 and KS-487 Multifunctionalized Nanoparticles Enable Efficient Brain Targeting for Treating Schizophrenia
Sakamoto, K., Iwata, S., Jin, Z., Chen, L., Miyaoka, T., Yamada, M., Katahira, K., Yokoyama, R., Ono, A., Asano, S., et al. (2024) · JACS Au · doi:10.1021/jacsau.4c00311 · Cited by 13
Ferroptosis in the neurovascular unit after spinal cord injury
Huang, Y., & Bai, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114943 · Cited by 15
Nanoparticles modified with glucose analogs to enhance the permeability of the blood–brain barrier and their accumulation in the epileptic brain
Meng, Q., Zhang, X., Chen, Y., Yang, H., Liu, J., Yang, Z., Lei, J., Lu, F., Hao, D., Feng, L., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02476a · Cited by 13
Recent advances in 3D models for multiparametric blood–brain barrier detection in microfluidic systems
Boncristiani, C., Gilio, A. D., Castro, F. D., Nardini, A., Palmisani, J., Vàzquez, R. M., de Gennaro, G., Fanizzi, F. P., Ciccarella, G., & Vergaro, V. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02499k · Cited by 14
Novel bioengineered MBenes for the treatment of Alzheimer's disease: An in-Sillico study
Dahri, M., Jahromi, A. M., Nikzad, A., Mohammadgholian, M., Rahmanian, M., Abolmaali, S. S., & Maleki, R. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1969288 · Cited by 12
Sweet tailoring of glyco-modulatory extracellular matrix-inspired biomaterials to target neuroinflammation
Rebelo, A. L., Chevalier, M. T., Russo, L., & Pandit, A. S. (2021) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2021.100321 · Cited by 14
The protective effects of Mirtazapine against lipopolysaccharide (LPS)-induced brain vascular hyperpermeability
Pu, Y., Zhao, L., Xi, Y., Xia, Y., & Qian, Y. (2022) · Bioengineered · doi:10.1080/21655979.2021.2024962 · Cited by 12
Visualization of blood-brain barrier disruption with dual-wavelength high-resolution photoacoustic microscopy
Wang, Y., Zhang, R., Chen, Q., Guo, H., Liang, X., Li, T., Qi, W., & Xi, L. (2022) · Biomedical Optics Express · doi:10.1364/boe.449017 · Cited by 12
Design of aggregation-induced emission-active fluorogen-based nanoparticles for imaging and scavenging Alzheimer's β-amyloid by photo-oxygenation
Liu, L., Liu, W., Sun, Y. P., & Dong, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01134h · Cited by 12
Netrin‐1 protects blood–brain barrier (BBB) integrity after cerebral ischemia‐reperfusion by activating the Kruppel‐like factor 2 (KLF2)/occludin pathway
Li, Y., Liu, C., Chen, Z., Lin, H., & Li, X. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23623 · Cited by 12
Molecular imaging-guided diagnosis and treatment integration for brain diseases
Yu, D., Liu, M., Ding, Q., Wu, Y., Wang, T., Song, L., Li, X., Qian, K., Cheng, Z., Gu, M., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123021 · Cited by 12
Peptide Gene Delivery Vectors for Specific Transfection of Glioma Cells
Wang, T., Meng, Z., Kang, Z., Ding, G., Zhao, B., Han, Z., Zheng, Z., Wang, C., & Meng, Q. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01336 · Cited by 12
Natural polymeric nanocarriers in malignant glioma drug delivery and targeting
Gao, Y., Wang, R., Zhao, L., & Liu, A. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1904250 · Cited by 12
Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
Li, T., Hou, X., Yu, Q., Duan, X., Yan, P., Zhu, H., Xie, Z., & Zhang, H. (2021) · Nano Research · doi:10.1007/s12274-021-3865-2 · Cited by 12
Applications of nanodiamonds in the diagnosis and treatment of neurological diseases
Tang, G. F., Zhang, M. R., Liu, Q., Tian, X., & R., R. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05434-2 · Cited by 13
Midazolam Ameliorates Impairment of the Blood–Brain Barrier (BBB) Against LPS
Zheng, J., Zhang, W., Kang, P., Zheng, X., He, K., Bai, H., & Yu, X. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00508-4 · Cited by 12
Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer
Naki, T., & Aderibigbe, B. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051048 · Cited by 14
Locally implantable nanofibre meshes by sustained release of temozolomide for combined thermo-chemotherapy to treat glioblastoma
Oe, E., Fujisawa, N., Chen, L., Uto, K., Matsumoto, Y., & Ebara, M. (2023) · New Journal of Chemistry · doi:10.1039/d3nj00534h · Cited by 11
Applications of Nanoparticles in Alzheimer’s Disease
Liu, Y., & Shen, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230098 · Cited by 12
Exposure of quantum dots in the nervous system: Central nervous system risks and the blood–brain barrier interface
Guan, S., & Tang, M. X. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4568 · Cited by 11
Bionic nanotheranostic for multimodal imaging-guided NIR-II-photothermal cancer therapy
Zhang, M., Zhang, Y., Hang, L., Zhang, T., Luo, C., Li, W., Sun, Y., Wen, H., Chen, Y., Jiang, G., et al. (2024) · Nanoscale · doi:10.1039/d4nr00230j · Cited by 11
Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics
Urbano‐Gámez, J. D., Guzzi, C., Bernal, M., Solivera, J., Martínez-Zubiaurre, I., Caro, C., & García‐Martín, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105213 · Cited by 13
Reactive oxygen species-responsive nanotherapy for the prevention and treatment of cerebral ischemia–reperfusion injury
Kong, J., Chu, R., Wen, J., Yu, H., Liu, J., Sun, Y., Mao, M., Ge, X., Jin, Z., Huang, W., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153023 · Cited by 11
Nanomaterial-Based Strategies for Attenuating T-Cell-Mediated Immunodepression in Stroke Patients: Advancing Research Perspectives
Wang, Y., Liu, C., Ren, Y., Song, J., Fan, K., Gao, L., Ji, X., Chen, X. S., & Zhao, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s456632 · Cited by 11
Self-citation
Herbal nanoparticles: a targeted approach for neurodegenerative disorder treatment
Panda, P., & Mohapatra, R. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2391913 · Cited by 11
Production and effects of nanomineral selenium (Nano-Se) feed additive on rumen fermentation, productivity, and reproductive performance of ruminants
Sitaresmi, P. I., Hudaya, M. F., Atmoko, B. A., Wulandari, W., & Ujilestari, T. (2024) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2024.k830 · Cited by 11
Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK/HIF‐1α/Glycolysis Pathway
Guo, Y., Jin, L., Shen, Z., Fan, L., Yu, X., Kuang, Y., Cai, L., Zhou, J., Chen, Z., Yan, F., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404782 · Cited by 11
Self-citation
Biomaterials in Alzheimer's Disease: An Anti‐Neuroinflammatory Perspective
Huang, N., Huang, W., Wang, M., Shi, J., Luo, Y., & Huang, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500498 · Cited by 13
Design, characterization of Resveratrol-Thermosensitive Hydrogel System (Res-THS) and evaluation of its anti-depressant effect via intranasal administration
Zhou, J., Duan, L., Wang, Y., Wang, C.-L., Tian, M., Qi, X., & Qiu, F. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.110597 · Cited by 11
Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases
Ramasubramanian, B., Reddy, V. S., Chellappan, V., & Ramakrishna, S. (2022) · Biosensors · doi:10.3390/bios12121176 · Cited by 13
Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases
Faouzi, A., & Roullin, G. (2021) · Pharmaceuticals · doi:10.3390/ph14020109 · Cited by 12
Theranostic of orthotopic gliomas by core-shell structured nanoplatforms
Carlos, L. D. (2022) · Light Science & Applications · doi:10.1038/s41377-022-00852-2 · Cited by 11
Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies
Wang, N., Qing, Q., Xue, Y., Cai, S., Zheng, M., Zhang, D., & Ismail, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114472 · Cited by 14
Turmeronols (A and B) from Curcuma longa have anti-inflammatory effects in lipopolysaccharide-stimulated BV-2 microglial cells by reducing NF-κB signaling
Saji, R., Uchio, R., Fuwa, A., Okuda-Hanafusa, C., KAWASAKI, K., Muroyama, K., Murosaki, S., Yamamoto, Y., & Hirose, Y. (2023) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2022-071 · Cited by 10
Recent advances in nanomedicine development for traumatic brain injury
Ling, Y., Ramalingam, M., Lv, X., Zeng, Y., Qiu, Y., Si, Y., Pedraz, J. L., Kim, H., & Hu, J. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102087 · Cited by 10
Nanomedicine revolutionizes epilepsy treatment: overcoming therapeutic hurdles with nanoscale solutions
Li, S., Zhang, W., Zhu, Y., Yao, Q., Chen, R., Kou, L., & Shi, X. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2360528 · Cited by 10
Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting
Ibrahim, R. M., Teaima, M. H. M., El-Nabarawi, M. A., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105885 · Cited by 12
Walnut-derived peptides cross the blood–brain barrier and ameliorate Aβ-induced hypersynchronous neural network activity
Min, W., Dang, Q., Li, Z., Zhao, X., Shen, Y., Li, F., & Liu, C. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115302 · Cited by 11
Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood–Brain Barrier and Actively Targeting Glioma Lesions
Liu, Y., Wu, H., & Liang, G. (2025) · Biomaterials Research · doi:10.34133/bmr.0133 · Cited by 10
Unlocking the human blood-brain barrier (BBB) characteristics for the development of nano-delivery strategies for central nervous system therapies
Gokce, C., Altun, B., Kirit, E., Yavuz, H., Uyar, R., Çelik, D., & Yılmazer, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106961 · Cited by 12
Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments
Liu, G., & Sun, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374149 · Cited by 11
LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
Luo, D., Han, L., Gao, S., Xiao, Z., Zhou, Q., Cheng, X., Zhang, Y., & Zhou, W. (2021) · Brain Sciences · doi:10.3390/brainsci11111411 · Cited by 10
Nanosized copper particles induced mesangial cell toxicity via the autophagy pathway
Xu, P., Cao, M., Dong, X., Yu, Z., Liu, J., Tan, J., Wang, Y., Li, T., & Zhao, S. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12252 · Cited by 10
Engineered inhalable nanocatalytic therapeutics for Parkinson's disease by inducing mitochondrial autophagy
Guo, M., Li, B., Feng, G., Su, X., Wang, X., Han, X., Yang, M., Bai, L., Zhu, X., Fan, H., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.111808 · Cited by 10
Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma
Cai, J.-Y., Liu, Y., Zhang, L., Guo, R., Liu, Y., Li, X., Ma, L.-Y., & Kong, L. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105387 · Cited by 10
The Effects of Various Surface Coatings of Gold Nanorods on Toxicity, Neuronal Localization, Microstructural Alterations, and In vitro/In vivo Biodistribution
Özçiçek, İ., Ayşit, N., Çakici, Ç., Aytürk, N., Aydeğer, A., & Erim, Ü. C. (2021) · Advanced Materials Interfaces · doi:10.1002/admi.202101369 · Cited by 10
A blood-brain barrier crossing peptide
Li, X., Zhang, Y., Wang, Y., Chen, Y., Xu, T., Wang, L., Gao, J., & Yang, Z. (2023) · Science China Materials · doi:10.1007/s40843-022-2484-1 · Cited by 9
Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer’s disease and Parkinson’s disease
Li, Y., Zhang, J., Ma, B., Yu, W., Xu, M., Luan, W., Yu, Q., Zhang, L., Rong, R., Fu, Y., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124786 · Cited by 10
Natural Cell‐Inspired Nanoparticles: Preparation, Mechanisms, Applications, and Prospects for Clinical Translation
Li, Y., Xiong, J., Yu, H., Wang, J., Wu, M., Lou, X., Zhou, L., Li, F., Dai, J. Y., & Xia, F. (2025) · Advanced Materials · doi:10.1002/adma.202505187 · Cited by 10
A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy
Zhang, Y., Qin, S., Song, T., Huang, Z., Lv, Z., Zhao, Y. C., Jiao, X., Sun, M., Zhang, Y., Xie, G., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.014 · Cited by 9
Advances in polysaccharides from traditional Chinese medicine for the treatment of central nervous system disorders: A comprehensive review
Song, F., Mei, Z., & Zhang, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149416 · Cited by 9
Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders
Zhu, T.-T., Liu, P., Hashimoto, K., & Yang, J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03603-6 · Cited by 10
Successful synthesis of a glial‐specific blood–brain barrier shuttle peptide following a fragment condensation approach on a solid‐phase resin
Musaimi, O. A., Morse, S. V., Lombardi, L., Şerban, S., Basso, A., & Williams, D. R. (2022) · Journal of Peptide Science · doi:10.1002/psc.3448 · Cited by 9
Determining the impact of gold nanoparticles on amyloid aggregation with 2D IR spectroscopy
Hess, K. A., Spear, N. J., Vogelsang, S. A., Macdonald, J. E., & Buchanan, L. E. (2023) · The Journal of Chemical Physics · doi:10.1063/5.0136376 · Cited by 9
Meropenem–Vaborbactam for the Treatment of Post-Neurosurgical Meningitis Caused by KPC Producer Klebsiella Pneumoniae: A Case Report and Review of the Literature
Rezzonico, L. F., Peracchi, F., Vecchi, M., Bassi, G., Merli, M., Bana, N. B., Travi, G., Crippa, F., & Puoti, M. (2024) · Antibiotics · doi:10.3390/antibiotics13040331 · Cited by 9
Nucleic Acid Delivery to the Vascular Endothelium
Reschke, M., Piotrowski-Daspit, A. S., Pober, J. S., & Saltzman, W. M. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00653 · Cited by 9
Neuronal maturation-dependent nano–neuro interaction and modulation
Gupta, P., Rathi, P., Gupta, R., Baldi, H., Coquerel, Q., Debnath, A., Derami, H. G., Raman, B., & Singamaneni, S. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00258f · Cited by 9
New advances in diagnosis and treatment of nano drug delivery systems across the blood-brain barrier
Wang, J., Yu, Y., Zhang, C., Song, J., Zheng, Z., & Wei-hong, Y. (2023) · Nanocomposites · doi:10.1080/20550324.2023.2256466 · Cited by 8
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9
Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer’s Disease
Bogadi, S., Bhaskaran, M., Ravichandran, V., Nesamony, J., Selvam, C., Kuppusamy, G., Prakash, G., Karri, V. V. S. R., Mallick, S., Farahim, F., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04917-2 · Cited by 10
Advances in CNS drug delivery strategies to cross the blood-brain barrier
Li, G., Li, Z., Sun, Y., Bu, T., Chen, S., Yang, L., Li, Z., Mao, W., & Jia, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111524 · Cited by 10
Interplay Between Aging and Glial Cell Dysfunction: Implications for CNS Health
García‐Domínguez, M. (2025) · Life · doi:10.3390/life15101498 · Cited by 12
Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging
Chen, Y., Ding, Y., Lin, H., & Shi, J. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01323b · Cited by 9
Potential nanotherapeutic strategies for perioperative stroke
An, J., Zhao, L., Duan, R., Sun, K., Lu, W., Yang, J., Liang, Y., Liu, J., Zhang, Z., Li, L., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13819 · Cited by 8
Lipid Nanocarriers as Precision Delivery Systems for Brain Tumors
Keshari, R., Dewani, M., Kaur, N., Patel, G. K., Singh, S. K., Chandra, P., Prasad, R., & Srivastava, R. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00007 · Cited by 8
Targeting the brain: various approaches and science involved
Bahadur, S., Naurange, T., Baghel, P., Sahu, M., & Yadu, K. (2020) · ScienceRise Pharmaceutical Science · doi:10.15587/2519-4852.2020.210824 · Cited by 8
Fluorination and Betaine Modification Augment the Blood–Brain Barrier‐Crossing Ability of Cylindrical Polymer Brushes
Wang, R., Yang, S., Xiao, P., Sun, Y., Li, J., Jiang, X., & Wu, W. (2022) · Angewandte Chemie · doi:10.1002/ange.202201390 · Cited by 8
A Calixarene Assembly Strategy of Combined Anti-Neuroinflammation and Drug Delivery Functions for Traumatic Brain Injury Therapy
Wang, C., Chang, Y., Chen, X., Bai, L., Wang, H., Pan, Y., Zhang, C., Guo, D., & Xue, X. (2022) · Molecules · doi:10.3390/molecules27092967 · Cited by 8
Self-citation
miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia
Figueroa, E. G., Caballero-Román, A., Grau, J. R. T., Carmona, M. M., Nardi-Ricart, A., & González‐Candia, A. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100129 · Cited by 8
Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases
Alharbi, K. S., Shaikh, M. A. J., Afzal, O., Altamimi, A. S. A., Almalki, W. H., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Babu, M. R., Singh, S. K., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103849 · Cited by 8
Targeted regulation of neuroinflammation via nanobiosignaler for repairing the central nerve system injuries
Sun, X., Ruan, H., Liu, Q., Cao, S., Jing, Q., Xu, Y., Xiong, L., Cui, W., & Li, C. (2022) · Nano Research · doi:10.1007/s12274-022-5143-3 · Cited by 8
Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models
Yin, P., & Wang, X. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25359 · Cited by 7
Lactoferrin-modified nanoemulsions enhance brain-targeting and therapeutic efficacy of arctigenin against Toxoplasma gondii-induced neuronal injury
Lu, J., Jin, G., Xin, Y., Jingwen, M., Shen, X.-Y., Quan, Y.-Z., Liu, Y., Zhou, J.-Y., Wang, B.-Z., Li, Y.-B., et al. (2024) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2024.100575 · Cited by 7
Advances in clinical neurorestorative treatments of Parkinson's disease
Yin, Y., Su, D., Lam, J. S. T., & Feng, T. (2025) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2025.100204 · Cited by 8

Authors: Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X.
Affiliations: Innovation Center of NanoMedicine (JP)
National Institutes of Health (US)
Corresponding author: Shen, Zheyu
Kataoka, Kazunori
Chen, Xiaoyuan
ORCID: Xie, Jinbing
Shen, Zheyu
Anraku, Yasutaka
Kataoka, Kazunori
Chen, Xiaoyuan
Venue: Biomaterials
Publisher: Elsevier BV
Published: 2019-12
Volume: 224
Pages: 119491
ISSN: 0142-9612 (ISSN-L)
DOI: 10.1016/j.biomaterials.2019.119491
PMC: PMC6915305
OpenAlex: W2973160898
Cited by: 604
References: 236
Citations by year: 2026: 64 · 2025: 131 · 2024: 116 · 2023: 104 · 2022: 92 · 2021: 57 · 2020: 38 · 2019: 2
FWCI: 4.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biomaterials (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, BBB crossing, nanomaterials, brain drug delivery, central nervous system disorders, intranasal drug delivery, blood-brain barrier disruption, cell-penetrating peptides, receptor-mediated transcytosis, theranostic agents
MeSH terms: Animals, Blood-Brain Barrier, Central Nervous System Diseases, Clinical Trials as Topic, Disease Models, Animal, Humans, Drug Delivery Systems, Nanostructures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks